| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1089 | 2021 |
| Clinical features and management of human monkeypox: a retrospective observational study in the UK H Adler, S Gould, P Hine, LB Snell, W Wong, CF Houlihan, JC Osborne, ... The Lancet Infectious Diseases 22 (8), 1153-1162, 2022 | 1063 | 2022 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 827 | 2022 |
| COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study VJ Hall, S Foulkes, A Saei, N Andrews, B Oguti, A Charlett, E Wellington, ... The Lancet 397 (10286), 1725-1735, 2021 | 786 | 2021 |
| SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) VJ Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, ... The Lancet 397 (10283), 1459-1469, 2021 | 689 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 448* | 2021 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 434 | 2021 |
| Universal heteroplasmy of human mitochondrial DNA BAI Payne, IJ Wilson, P Yu-Wai-Man, J Coxhead, D Deehan, R Horvath, ... Human molecular genetics 22 (2), 384-390, 2013 | 424 | 2013 |
| First experience of COVID-19 screening of health-care workers in England E Hunter, DA Price, E Murphy, IS van der Loeff, KF Baker, D Lendrem, ... The Lancet 395 (10234), e77-e78, 2020 | 378 | 2020 |
| Mitochondrial dysfunction in aging: much progress but many unresolved questions BAI Payne, PF Chinnery Biochimica et Biophysica Acta (BBA)-Bioenergetics 1847 (11), 1347-1353, 2015 | 378 | 2015 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 359 | 2021 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 322 | 2021 |
| Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine RP Payne, S Longet, JA Austin, DT Skelly, W Dejnirattisai, S Adele, ... Cell 184 (23), 5699-5714. e11, 2021 | 278 | 2021 |
| Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations BAI Payne, IJ Wilson, CA Hateley, R Horvath, M Santibanez-Koref, ... Nature genetics 43 (8), 806-810, 2011 | 270 | 2011 |
| Segregation of mitochondrial DNA heteroplasmy through a developmental genetic bottleneck in human embryos VI Floros, A Pyle, S Dietmann, W Wei, WCW Tang, N Irie, B Payne, ... Nature cell biology 20 (2), 144-151, 2018 | 193 | 2018 |
| T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study A Angyal, S Longet, SC Moore, RP Payne, A Harding, T Tipton, ... The Lancet Microbe 3 (1), e21-e31, 2022 | 176 | 2022 |
| Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance G Pfeffer, GS Gorman, H Griffin, M Kurzawa-Akanbi, EL Blakely, I Wilson, ... Brain 137 (5), 1323-1336, 2014 | 175 | 2014 |
| Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection AT Hanrath, BAI Payne, CJA Duncan Journal of Infection 82 (4), e29-e30, 2021 | 133 | 2021 |
| HIV Treatment and Associated Mitochondrial Pathology: Review of 25 Years of in Vitro, Animal, and Human Studies K Gardner, PA Hall, PF Chinnery, BAI Payne Toxicologic pathology 42 (5), 811-822, 2014 | 123 | 2014 |
| Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant P Elliott, D Haw, H Wang, O Eales, CE Walters, KEC Ainslie, C Atchison, ... Science 374 (6574), eabl9551, 2021 | 121 | 2021 |
Patrick F ChinneryUniversity of Cambridge在 medschl.cam.ac.uk 的电子邮件经过验证
